Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

732
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
732
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

288
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
288

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrastructural study on human placentae from women subjected to assisted reproductive technology treatments.

Biology of reproduction·2011
Same author

Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2011
Same author

Lathyrane diterpenoids from the roots of Euphorbia micractina and their biological activities.

Journal of natural products·2011
Same author

Quantification of sofalcone in human plasma and urine by high performance liquid chromatography-mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2011
Same author

A densely overlapping gene fragmentation approach improves yeast two-hybrid screens for Plasmodium falciparum proteins.

Molecular and biochemical parasitology·2011
Same author

Seedling growth and metal accumulation of selected woody species in copper and lead/zinc mine tailings.

Journal of environmental sciences (China)·2011

Related Experiment Video

Updated: Oct 10, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Multi-resolution 3D-HOG feature learning method for Alzheimer's Disease diagnosis.

Zhiyuan Ding1, Yan Liu2, Xu Tian2

  • 1School of Information and Communication Engineering, University of Electronic Science and Technology of China, Chengdu, China.

Computer Methods and Programs in Biomedicine
|December 13, 2021
PubMed
Summary

Early Alzheimer's Disease (AD) identification is crucial. This study introduces a novel method using spatial pyramid 3D-HOG features for explainable AD detection, showing promising results in clinical datasets.

Keywords:
Alzheimer’s DiseaseFeature learningHOGMulti-resolution

More Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.3K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.4K

Related Experiment Videos

Last Updated: Oct 10, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.3K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.4K

Area of Science:

  • Neuroimaging analysis
  • Medical image processing
  • Biomedical engineering

Background:

  • Alzheimer's Disease (AD) is a progressive neurodegenerative disorder.
  • Timely identification of AD is critical for managing disease progression.
  • Current diagnostic methods require improvement for early and explainable detection.

Purpose of the Study:

  • To develop a discriminative feature extraction and selection strategy for explainable AD identification.
  • To propose a spatial pyramid based 3D-HOG (SPHOG) feature learning method.
  • To enhance the accuracy and interpretability of AD diagnosis.

Main Methods:

  • Utilized spatial pyramid based 3D-HOG (SPHOG) for feature extraction, capturing global and local texture changes.
  • Employed a modified wrapper-based feature selection algorithm to identify discriminative features and reduce dimensionality.
  • Validated the approach on both common and clinical datasets.

Main Results:

  • Selected discriminative SPHOG histograms at various resolutions effectively represent cerebral cortex atrophy.
  • The identified subareas align with clinical expertise, emphasizing the method's explainability.
  • Demonstrated promising performance in AD identification using the proposed feature learning strategy.

Conclusions:

  • The proposed SPHOG feature learning method is effective for AD identification.
  • The method's explainability is highlighted, particularly with reference to the Hippocampus.
  • This approach holds potential for early AD diagnosis and further medical analysis of other brain ROIs.